Glaxosmithkline Pharma
May 07, 2012 at 14:27 | Source: Moneycontrol.com
Apr 09, 2012 at 14:46 | Source: Moneycontrol.com
Apr 02, 2012 at 09:46 | Source: Reuters
Mar 13, 2012 at 15:47 | Source: Moneycontrol.com
Mar 02, 2012 at 12:46 | Source: Moneycontrol.com
News across the web »
May 08, 2012 at 04:52 | Source: FirstPost
May 07, 2012 at 14:01 | Source: FirstPost
May 07, 2012 at 13:36 | Source: FirstPost
May 07, 2012 at 09:36 | Source: FirstPost
Nov 08, 2011 at 20:56 | Source: Livemint
Interact & exchange stock tips & market info »
Related News »
(RTTNews) - Auxilium Pharmaceuticals, Inc. (AUXL: News ) and GlaxoSmithKline LLC, the U.S. subsidiary of GlaxoSmithKline plc (GSK: News ,GSK.L: News ), announced that they have entered into an agreement for the co-promotion of Testim 1% (testosterone gel ...
May 21, 2012 at 11:15 | Source: RTT News
Auxilium Pharmaceuticals Inc. issued certain guidance information related to their 2012 financial performance and co-promotion agreement with GlaxoSmithKline. (Earlier headlines from 7 a.m. to 7:06 a.m. EDT incorrectly attributed certain ...
May 21, 2012 at 12:05 | Source: FOXBusiness
GlaxoSmithKline LLC. The companies signed an agreement for the co-promotion of Auxilium Pharma’s Testim (1% testosterone), which is approved for the treatment of hypogonadism or low testosterone level. Deal Terms The deal provides Glaxo with ...
May 22, 2012 at 13:22 | Source: Yahoo Finance
As new drug resistant superbugs such as the "New Delhi" bug have emerged, GlaxoSmithKline and AstraZeneca have teamed up with academics and other Big Pharma companies to tackle antibiotic resistance, which is becoming a major health threat around the world.
May 25, 2012 at 13:05 | Source: Phramalive.com
British pharma giant GlaxoSmithKline ( GSK) recently announced that it has completed the acquisition of 10,000,000 shares of biopharmaceutical company Theravance Inc. ( THRX). Shares were acquired for approximately $21.2887 per share.
May 17, 2012 at 17:39 | Source: NASDAQ
Social network Facebook (NASDAQ:FB) again was under the spotlight today after shareholders filed a lawsuit against is founder and CEO Mark Zuckerberg, claiming that he along with some banks including Morgan Stanley failed to disclose information in the ...
May 23, 2012 at 16:56 | Source: proactiveinvestors.com
Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company with a focus on developing and marketing products to predominantly specialist audiences, and GlaxoSmithKline LLC, the US subsidiary of GlaxoSmithKline plc (GSK), have entered into an ...
May 22, 2012 at 10:16 | Source: pharmabiz.com
GlaxoSmithKline LLC is expected to co-promote Testim with ... in 46 countries in Eurasia; Asahi Kasei Pharma Corporation has development and commercial rights for XIAFLEX in Japan; and Actelion Pharmaceuticals Ltd has development and commercial ...
May 29, 2012 at 01:33 | Source: Yahoo Finance
GlaxoSmithKline ($GSK) has shown in a series of M&A and ... However, other biotech companies enter collaborations with pharma giants such as GSK in hopes of being acquired. GSK scooped up Cellzome in a £61 million ($96 million) deal earlier ...
May 25, 2012 at 14:52 | Source: FierceBiotech
As new drug resistant superbugs such as the "New Delhi" bug have emerged, GlaxoSmithKline and AstraZeneca have teamed up with academics and other Big Pharma companies to tackle antibiotic resistance, which is becoming a major health threat around the world.
May 25, 2012 at 09:23 | Source: Director of Finance online